Literature DB >> 29812954

The Importance of Tyrosine Phosphorylation Control of Cellular Signaling Pathways in Respiratory Disease: pY and pY Not.

Yael Aschner1, Gregory P Downey1,2,3,4,5.   

Abstract

Reversible phosphorylation of proteins on tyrosine residues is an essential signaling mechanism by which diverse cellular processes are closely regulated. The tight temporal and spatial control of the tyrosine phosphorylation status of proteins by protein tyrosine kinases (PTKs) and protein tyrosine phosphatases (PTPs) is critical to cellular homeostasis as well as to adaptations to the external environment. Via regulation of cellular signaling cascades involving other protein kinases and phosphatases, receptors, adaptor proteins, and transcription factors, PTKs and PTPs closely control diverse cellular processes such as proliferation, differentiation, migration, inflammation, and maintenance of cellular barrier function. Given these key regulatory roles, it is not surprising that dysfunction of PTKs and PTPs is important in the pathogenesis of human disease, including many pulmonary diseases. The roles of various PTKs and PTPs in acute lung injury and repair, pulmonary fibrosis, pulmonary vascular disease, and inflammatory airway disease are discussed in this review. It is important to note that although there is overlap among many of these proteins in various disease states, the mechanisms by which they influence the pathogenesis of these conditions differ, suggesting wide-ranging roles for these enzymes and their potential as therapeutic targets.

Entities:  

Keywords:  kinase; phosphatase; phosphorylation

Mesh:

Substances:

Year:  2018        PMID: 29812954      PMCID: PMC6236691          DOI: 10.1165/rcmb.2018-0049TR

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  185 in total

Review 1.  The SHP-2 tyrosine phosphatase: signaling mechanisms and biological functions.

Authors:  C K Qu
Journal:  Cell Res       Date:  2000-12       Impact factor: 25.617

Review 2.  Cell signaling by receptor tyrosine kinases.

Authors:  J Schlessinger
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 3.  JAK-STAT signaling in asthma.

Authors:  Alessandra B Pernis; Paul B Rothman
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 4.  Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?

Authors:  A R L Medford; A B Millar
Journal:  Thorax       Date:  2006-07       Impact factor: 9.139

Review 5.  Airway inflammation in chronic obstructive pulmonary disease.

Authors:  Nikolaos Angelis; Konstantinos Porpodis; Paul Zarogoulidis; Dionysios Spyratos; Ioannis Kioumis; Antonis Papaiwannou; Georgia Pitsiou; Kosmas Tsakiridis; Andreas Mpakas; Stamatis Arikas; Theodora Tsiouda; Nikolaos Katsikogiannis; Ioanna Kougioumtzi; Nikolaos Machairiotis; Michael Argyriou; George Kessisis; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

6.  In vivo role of platelet-derived growth factor-BB in airway smooth muscle proliferation in mouse lung.

Authors:  Jeremy A Hirota; Kjetil Ask; Laszlo Farkas; Jane Ann Smith; Russ Ellis; Juan Carlos Rodriguez-Lecompte; Martin Kolb; Mark D Inman
Journal:  Am J Respir Cell Mol Biol       Date:  2011-01-07       Impact factor: 6.914

7.  Overexpression of fibroblast growth factor-10 during both inflammatory and fibrotic phases attenuates bleomycin-induced pulmonary fibrosis in mice.

Authors:  Varsha V Gupte; Suresh K Ramasamy; Raghava Reddy; Jooeun Lee; Paul H Weinreb; Shelia M Violette; Andreas Guenther; David Warburton; Barbara Driscoll; Parviz Minoo; Saverio Bellusci
Journal:  Am J Respir Crit Care Med       Date:  2009-06-04       Impact factor: 21.405

Review 8.  Cell-surface receptors transactivation mediated by g protein-coupled receptors.

Authors:  Fabio Cattaneo; Germano Guerra; Melania Parisi; Marta De Marinis; Domenico Tafuri; Mariapia Cinelli; Rosario Ammendola
Journal:  Int J Mol Sci       Date:  2014-10-29       Impact factor: 5.923

Review 9.  Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic?

Authors:  Paul J Wolters; Timothy S Blackwell; Oliver Eickelberg; James E Loyd; Naftali Kaminski; Gisli Jenkins; Toby M Maher; Maria Molina-Molina; Paul W Noble; Ganesh Raghu; Luca Richeldi; Marvin I Schwarz; Moises Selman; Wim A Wuyts; David A Schwartz
Journal:  Lancet Respir Med       Date:  2018-02       Impact factor: 30.700

Review 10.  EGF receptor trafficking: consequences for signaling and cancer.

Authors:  Alejandra Tomas; Clare E Futter; Emily R Eden
Journal:  Trends Cell Biol       Date:  2013-11-29       Impact factor: 20.808

View more
  5 in total

1.  Protein tyrosine phosphatase-α amplifies transforming growth factor-β-dependent profibrotic signaling in lung fibroblasts.

Authors:  Yael Aschner; Meghan Nelson; Matthew Brenner; Helen Roybal; Keriann Beke; Carly Meador; Daniel Foster; Kelly A Correll; Paul R Reynolds; Kelsey Anderson; Elizabeth F Redente; Jennifer Matsuda; David W H Riches; Steve D Groshong; Ambra Pozzi; Jan Sap; Qin Wang; Dhaarmini Rajshankar; Christopher A G McCulloch; Rachel L Zemans; Gregory P Downey
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-06-03       Impact factor: 5.464

2.  PTPα promotes fibroproliferative responses after acute lung injury.

Authors:  Yael Aschner; Kelly A Correll; Keriann M Beke; Daniel G Foster; Helen M Roybal; Meghan R Nelson; Carly L Meador; Matthew Strand; Kelsey C Anderson; Camille M Moore; Paul R Reynolds; Katrina W Kopf; Ellen L Burnham; Gregory P Downey
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-06-07       Impact factor: 6.011

3.  Profibrotic epithelial TGF-β1 signaling involves NOX4-mitochondria cross talk and redox-mediated activation of the tyrosine kinase FYN.

Authors:  Carmen Veith; Milena Hristova; Karamatullah Danyal; Aida Habibovic; Christopher M Dustin; John E McDonough; Bart M Vanaudenaerde; Michael Kreuter; Marc A Schneider; Nicolas Kahn; Frederik J van Schooten; Agnes W Boots; Albert van der Vliet
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-12-16       Impact factor: 5.464

4.  Tyrosine phosphorylation differentially fine-tunes ionotropic and metabotropic responses of human α7 nicotinic acetylcholine receptor.

Authors:  Juan Facundo Chrestia; Ariana Bruzzone; María Del Carmen Esandi; Cecilia Bouzat
Journal:  Cell Mol Life Sci       Date:  2021-05-24       Impact factor: 9.261

5.  Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors.

Authors:  Semih Başcı; Naim Ata; Fevzi Altuntaş; Tuğçe Nur Yiğenoğlu; Mehmet Sinan Dal; Serdal Korkmaz; Sinem Namdaroğlu; Abdülkadir Baştürk; Tuba Hacıbekiroğlu; Mehmet Hilmi Doğu; İlhami Berber; Kürşat Dal; Mehmet Ali Erkurt; Burhan Turgut; Murat Çağlayan; Mustafa Okan Ayvalı; Osman Çelik; Mustafa Mahir Ülgü; Şuayip Birinci
Journal:  J Oncol Pharm Pract       Date:  2020-08-27       Impact factor: 1.809

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.